Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021
- PMID: 36573643
- PMCID: PMC9796197
- DOI: 10.3201/eid2901.221514
Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021
Abstract
During November-December 2021, we performed a SARS-CoV-2 seroprevalence survey in Central and Western Divisions of Fiji. A total of 539 participants 8-70 years of age were 95.5% (95% CI 93.4%-97.1%) seropositive, indicating high community levels of immunity. Seroprevalence studies can inform public health responses to emerging SARS-CoV-2 variants.
Keywords: COVID-19; Fiji; Pacific Islands; SARS; SARS-CoV-2; antibodies; coronavirus; coronavirus disease; disease outbreak; respiratory infections; seroepidemiologic studies; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
References
-
- Fiji Ministry of Health and Medical Services. COVID-19 update—29-10-2021 [cited 2021 Nov 19]. https://www.health.gov.fj/29-10-2021
-
- Bergeri I, Whelan MG, Ware H, Subissi L, Nardone A, Lewis HC, et al.; Unity Studies Collaborator Group. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies. PLoS Med. 2022;19:e1004107. 10.1371/journal.pmed.1004107 - DOI - PMC - PubMed
-
- Fiji Bureau of Statistics. 2017. Population and housing census—release 1 [cited 2021 Nov 19]. https://www.statsfiji.gov.fj/index.php/census-2017/census-2017-release-1
-
- World Health Organization. Population-based age-stratified seroepidemiological investigation protocol for coronavirus 2019. (COVID-19) infection. 26 May 2020 [cited 2021 Nov 19]. https://www.who.int/publications/i/item/WHO-2019-nCoV-Seroepidemiology-2...
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical